-64.19(-0.17%) Nasdaq -144.87(-0.92%) Russell 2000 -28.60(-1.41%) -0.92(-1.16%) Gold +11.60(+0.57%) Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time …Jan 16, 2024 · The ups and downs of stock prices are often likened to a roller-coaster ride—and this past month, investors in Cytokinetics (CYTK) have seen all too well the ups, and the downs, of that metaphor ... Feb 13, 2024 · The Cytokinetics stock price gained 3.21% on the last trading day (Friday, 23rd Feb 2024), rising from $75.59 to $78.02. During the last trading day the stock fluctuated 4.79% from a day low at $75.86 to a day high of $79.49. The price has fallen in 6 of the last 10 days and is down by -1.17% for this period. Shares of Cytokinetics jumped after The Wall Street Journal reported that Novartis was close to acquiring the company. Shares of Cytokinetics, which is developing a promising heart drug, were ...Dec 28, 2023 · The biotech company showed 0% earnings growth in its most recent report. Sales rose -85%. Cytokinetics stock earns the No. 149 rank among its peers in the Medical-Biomed/Biotech industry group. Their CYTK share price targets range from $42.00 to $108.00. On average, they anticipate the company's stock price to reach $73.94 in the next twelve months. …CYTK, Cytokinetics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines RESEARCH. Shopping Cart. Your ... How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month Investor's Business Daily 02/09/2024 10:01 AM ET. Dow Jones ...Cytokinetics will settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at Cytokinetics’ election. The initial conversion rate is 19.5783 shares of common stock per $1,000 principal amount of notes, which represents an initial conversion price …CYTK Cytokinetics · High. 78.000 · Low. 76.010 · Volume. 1.14M · Open. 76.620 · Pre Close. 76.890 · Turnover. 87.30M · Turnover Rat...Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks. View the real-time CYTK price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper ...December 29, 2023. Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Free Report) rose 2.1% on Friday after StockNews.com upgraded the stock from a sell rating to a hold rating. The company traded as high as $85.50 and last traded at $85.01. Approximately 1,276,714 shares traded hands during mid-day trading, an increase of 2% from the average ...The stock extended its rally into 2024 despite markets struggling in the new year. ... CYTK Price Action: Shares of Cytokinetics were down 6.48% at $101.06 at the time of publication, ...The opening auction price ticked up from the premarket to $78.46, on a much higher volume than typical for the last 30 days. The stock showed some weakness ...-64.19(-0.17%) Nasdaq -144.87(-0.92%) Russell 2000 -28.60(-1.41%) -0.92(-1.16%) Gold +11.60(+0.57%) Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time …Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.According to the current price, Cytokinetics is 292.92% away from the 52-week low. What was the 52-week high for Cytokinetics stock? The high in the last 52 weeks of Cytokinetics stock was 110.00. Stock Chart; Historical Price Lookup; Data Provided by Refinitiv. Minimum 15 minutes delayed. More Resources. Site - Investor Relations. Stock Information. ... (e.g., manuscripts, posters and/or oral presentations that contain data from Cytokinetics-sponsored studies, have Cytokinetics authors, or for which Cytokinetics provides …CYTK stock forecast for 2023 – 2027. Last updated: November 14, 2023. Cytokinetics, Incorporated. 32.44 D 2.40% (0.76) Are you interested in Cytokinetics, Incorporated stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CYTK stock price in 2022-2027. Is CYTK a good long term …Cytokinetics (CYTK) closed the last trading session at $35.10, gaining 29.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...Feb 13, 2024 · Analyst Salim Syed of Mizuho Securities maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price target of $103.00. Salim Syed has given his Buy rating due to a combination ... Stock Price Forecast. The 17 analysts with 12-month price forecasts for Cytokinetics stock have an average target of 73.76, with a low estimate of 49 and a high ...The stock extended its rally into 2024 despite markets struggling in the new year. ... CYTK Price Action: Shares of Cytokinetics were down 6.48% at $101.06 at the time of publication, ...Jan 9, 2024 · Shares of Cytokinetics, Incorporated (CYTK Quick Quote CYTK - Free Report) ... This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating ... CYTK, Cytokinetics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines RESEARCH. Shopping Cart. Your ... How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month Investor's Business Daily 02/09/2024 10:01 AM ET. Dow Jones ...Find the historical stock prices of Cytokinetics (CYTK)3 days ago · Rates Futures Crypto Home Investing Quotes Stocks United States CYTK Overview Stock Screener Earnings Calendar Sectors Nasdaq | CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list NEW Set a price... B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Cytokinetics (CYTK – Research Report) yesterday and set a price target of $122.00. Mayank Mamtani’s Buy rating is based on ...B. Riley started coverage on Cytokinetics in a research report on Tuesday, November 7th. They set a "buy" rating and a $66.00 target price on the stock. UBS …Here's why making dividend investing a primary strategy as you build your retirement portfolio may not be the best decision. Is building a dividend portfolio a good idea, and what ...-61.55(-0.16%) -77.25 Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 76.62 -0.27 (-0.35%) As of 11:08AM …Jan 16, 2024 ... Cytoknetics shares climbed 9% on the report, from $32.09 to $34.86, only to stay relatively flat in the low- to mid-$30s per share range for a ...Shares of Cytokinetics with a market capitalization of over $9 billion, as of Friday's closing price, have more than tripled in value since Oct. 31, when reports of the company attracting takeover ...Find the latest Cytek Biosciences, Inc. (CTKB) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing.In depth view into CYTK (Cytokinetics) stock including the latest price, news, dividend history, earnings information and financials. Cytokinetics Inc (CYTK) 76.89 -1.67 ( -2.13% ) USD | NASDAQ | Feb 16, 16:00 Real time Cytokinetics (CYTK) stock price quote, stock graph, news & analysis.Get Cytokinetics Inc (CYTK.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsCYTK: Cytokinetics Inc Stock Price Quote - NASDAQ GS - Bloomberg Subscribe S&P 500 4,886.44 –0.78% Nasdaq 15,239.15 –1.75% Crude Oil 75.74 –2.67% Euro 1.08 …Cytokinetics, Incorporated Common Stock (CYTK) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Cytokinetics, Incorporated (KK3A.FRA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | Deutsche Boerse ...CYTK stock tacked on another 15%-plus on Jan. 8 when a rumor suggested Novartis could be entertaining a buyout bid for Cytokinetics. That put CYTK stock's gain at more than 141% over two weeks.Published: Dec. 27, 2023 at 7:43 a.m. ET. By Denny Jacob. Cytokinetics shares surged 42% to $65 in premarket trading after announcing positive topline results from a trial of aficamten in patients ... Get Cytokinetics Inc (CYTK.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsThe intrinsic value of one CYTK stock under the Base Case scenario is 16.76 USD. Compared to the current market price of 76.89 USD, Cytokinetics Inc is ...Today, it's easy to get free stocks! In most cases, all you have to do is sign up for one of the investing apps on this list. Getting free stocks is simple - all you have to do is ...Cytokinetics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CYTK updated stock price target summary.Analyst Salim Syed of Mizuho Securities maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price target of $103.00. Salim Syed has given his Buy rating due to a combination ...The average Cytokinetics stock price prediction forecasts a potential upside of 10.28% from the current CYTK share price of $75.59. What is CYTK's forecast ...The analyst Sean McCutcheon increased the price target for CYTK from $63 to $92, which reflects a potential buyout price in the range of 4x EV/5-year forward (2029E) projected sales aficamten. The ...Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price.Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...What is Cytokinetics Inc(CYTK)'s stock price today? The current price of CYTK is $76.89. The 52 week high of CYTK is $110.25 and 52 week low is $25.98. When is next earnings date of Cytokinetics Inc(CYTK)? The next earnings date of Cytokinetics Inc(CYTK) is 2024-02-27. Does Cytokinetics Inc(CYTK) pay dividends? ...Jan 12, 2024 · Shares of Cytokinetics plummeted further Thursday after the Journal reported that Novartis has backed away from a deal to acquire the heart-drug developer. Cytokinetics stock was recently down 24%. Five grants in the amount of $20,000 each were awarded this year to patient advocacy organizations. Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing.Cytokinetics has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%. Is Cytokinetics Stock Undervalued? The current Cytokinetics [ CYTK] share price is $76.89. The Score for CYTK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.Cytokinetics to Announce Fourth Quarter Results on February 27, 2024. Globe Newswire • 10 days ago. Track Cytokinetics Inc (CYTK) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...Spruce Biosciences Inc. $5.09 $0.03 (0.59%) Thinking about buying or selling stock in CYTK? See the latest Cytokinetics (CYTK) stock analysis, price, forecast, news and more.On February 9, 2024, Cytokinetics, Incorporated (NASDAQ:CYTK) stock closed at $76.94 per share. One-month return of Cytokinetics, Incorporated (NASDAQ:CYTK) was -10.12%, and its shares gained 76. ...See the company profile for Cytokinetics, Incorporated (CYTK) including business summary, ... NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 76.89-1.67 (-2 ...-- Cytokinetics has an average rating of outperform and price targets ranging from $42.40 to $122, according to analysts polled by Capital IQ. Price: 81.22, Change: -1.52, Percent Change: -1.84 ...CYTK Stock 12 Months Forecast. $92.00. (11.52% Upside) Based on 17 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The average price target is $92.00 with a high forecast of $122.00 and a low forecast of $54.00. The average price target represents a 11.52% change from the last price of $82.50.57,973.31 -165.23(-0.28%) Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Add to watchlist 81.87 +0.62 (+0.76%) At close: …The potential price and other terms couldn’t be learned. Cytokinetics is focused on so-called muscle activators and inhibitors as ... The Motley Fool: Epic Bundle - 3x Expert Stock ...View Cytokinetics (CYTK) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the ...Get the latest information on Cytokinetics, Incorporated Common Stock (CYTK) including its bid and ask prices, market cap, news and history. See how CYTK performed on Nasdaq and other global markets. Cytokinetics, Incorporated Common Stock (CYTK) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. The Cytokinetics stock price fell by -2.86% on the last day (Tuesday, 13th Feb 2024) from $79.30 to $77.03. During the last trading day the stock fluctuated 5.88% from a day low at $76.21 to a day high of $80.69. The price has fallen in 5 of the last 10 days and is down by -2.16% for this period. Volume has increased on the last day by 1 ...B. Riley started coverage on Cytokinetics in a research report on Tuesday, November 7th. They set a "buy" rating and a $66.00 target price on the stock. UBS …The biotech company showed 0% earnings growth in its most recent report. Sales rose -85%. Cytokinetics stock earns the No. 149 rank among its peers in the Medical-Biomed/Biotech industry group.Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 …Cytokinetics Stock Earnings. The value each CYTK share was expected to gain vs. the value that each CYTK share actually gained. Cytokinetics ( CYTK) reported Q3 2023 earnings per share (EPS) of -$1.35, missing estimates of -$0.74 by 81.36%. In the same quarter last year, Cytokinetics 's earnings per share (EPS) was -$1.52. 3 days ago · Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 Week Low: US ... Feb 16, 2024 · CYTK, Cytokinetics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Stock Quote. Stock Information. Stock Quote; Stock Chart; Historical Price Lookup ... posters and/or oral presentations that contain data from Cytokinetics-sponsored ... Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Data is delayed at least 15 minutes.Stock Chart; Historical Price Lookup; Change. Volume. Today's Open. Previous Close. Today's High. Today's Low. 52 Week High. 52 Week Low. Data Provided by ... (e.g., …Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy. Stock split history for Cytokinetics since 2004.Interactive stock price chart for Cytokinetics, Incorporated (CYTK) with real-time updates, full price history, technical analysis and more.Stock Cytokinetics, Incorporated - Nasdaq . News Cytokinetics, Incorporated. UBS Trims Cytokinetics' Price Target to $61 From $62, Keeps Buy Rating. Best financial portal +951% of historical performance More than 20 years at your side ...Real time Cytokinetics (CYTK) stock price quote, stock graph, news & analysis.Cytokinetics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CYTK updated stock price target summary.
View Cytokinetics (CYTK) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the .... Air jordan 4 red cement shock drop
Stock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Cytokinetics, Incorporated (KK3A.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | BOERSE MUENCHEN ...Amgen Inc. -0.99%. $164.04B. CYTK | Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Stock Chart; Historical Price Lookup; Change. Volume. Today's Open. Previous Close. Today's High. Today's Low. 52 Week High. 52 Week Low. Data Provided by ... (e.g., manuscripts, posters and/or oral presentations that contain data from Cytokinetics-sponsored studies, have Cytokinetics authors, or for which Cytokinetics provides …CYTK stock forecast for 2023 – 2027. Last updated: November 14, 2023. Cytokinetics, Incorporated. 32.44 D 2.40% (0.76) Are you interested in Cytokinetics, Incorporated stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CYTK stock price in 2022-2027. Is CYTK a good long term …Apellis Pharmaceuticals Inc. 68.78. +1.20. +1.78%. Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference; The biotech stocks to own in 2024, according to Piper Sandler; Cytokinetics price target raised to $78 from $48 at ...ugurhan. Morgan Stanley downgraded its rating of Cytokinetics (NASDAQ:CYTK) to equal weight, but raised its price target, stating it saw the shares approaching full valuation.The investment bank ...According to the current price, Cytokinetics is 292.92% away from the 52-week low. What was the 52-week high for Cytokinetics stock? The high in the last 52 weeks of Cytokinetics stock was 110.00. Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy. Stock split history for Cytokinetics since 2004.01-Jan-2017. $4M. $14.9M. 0000. Completed. Pre-Clinical Trials. To view Cytonics’s complete valuation and funding history, request access ».Amgen Inc. -0.99%. $164.04B. CYTK | Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.CYTK) stock’s latest price update. Cytokinetics Inc (NASDAQ: CYTK) has seen a decline in its stock price by -1.19 in relation to its previous close of 76.50. However, the company has experienced a -1.19% decline in its stock price over the last five trading sessions. GlobeNewsWireCytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it looks to take on Bristol in heart disease. Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to …Cytokinetics, Incorporated Common Stock (CYTK) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Cytokinetics, Inc. (CYTK) Stock Price & News - Google Finance Markets Dow Jones 39,069.11 +1.18% +456.87 S&P 500 5,087.03 +2.11% +105.23 Nasdaq 16,041.62 +2.96% +460.75 2,013.84 +0.96% +19.09... Stock split history for Cytokinetics (CYTK) Cytokinetics stock (symbol: CYTK) underwent a total of 1 stock split. The stock split occured on June 25th, 2013. One CYTK share bought prior to June 25th, 2013 would equal to ….